AlphaMark Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$7K Hold
50
﹤0.01% 480
2024
Q3
$7K Hold
50
﹤0.01% 544
2024
Q2
$7K Hold
50
﹤0.01% 575
2024
Q1
$7K Hold
50
﹤0.01% 578
2023
Q4
$7K Hold
50
﹤0.01% 561
2023
Q3
$6K Hold
50
﹤0.01% 568
2023
Q2
$6K Hold
50
﹤0.01% 464
2023
Q1
$6K Hold
50
﹤0.01% 477
2022
Q4
$7K Sell
50
-15
-23% -$1.94K ﹤0.01% 420
2022
Q3
$8K Sell
65
-20
-24% -$2.48K ﹤0.01% 446
2022
Q2
$10K Sell
85
-35
-29% -$4.16K ﹤0.01% 395
2022
Q1
$16K Sell
120
-275
-70% -$35.8K 0.01% 358
2021
Q4
$60K Buy
395
+10
+3% +$1.55K 0.02% 219
2021
Q3
$62K Hold
385
0.02% 218
2021
Q2
$63K Buy
385
+155
+67% +$23.9K 0.02% 214
2021
Q1
$35K Hold
230
0.01% 261
2020
Q4
$35K Buy
230
+30
+15% +$4.29K 0.01% 240
2020
Q3
$27K Buy
+200
New +$27.1K 0.01% 254
2015
Q1
Sell
-570
Closed -$58K 307
2014
Q4
$58K Sell
570
-915
-62% -$88.9K 0.04% 141
2014
Q3
$135K Sell
1,485
-360
-20% -$31.6K 0.09% 108
2014
Q2
$158K Buy
1,845
+390
+27% +$30.7K 0.09% 107
2014
Q1
$115K Buy
+1,455
New +$121K 0.07% 118
2013
Q3
Sell
-300
Closed -$17K 341
2013
Q2
$17K Buy
+300
New +$17.3K 0.01% 254

Other funds holding IBB

AlphaMark Advisors's IBB Position: Q4 2024 in Review

AlphaMark Advisors held its iShares Biotechnology ETF (IBB) position steady in Q4 2024 at 50 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

AlphaMark Advisors first reported a position in IBB in Q2 2013 and has held it in 23 quarters since. The position peaked at $158K in Q2 2014. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • AlphaMark Advisors held 50 shares of iShares Biotechnology ETF worth $7K as of Q4 2024.
  • AlphaMark Advisors left its iShares Biotechnology ETF share count unchanged in Q4 2024.
  • iShares Biotechnology ETF made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #480 holding.
  • AlphaMark Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 23 quarters since.
  • AlphaMark Advisors's iShares Biotechnology ETF position peaked at $158K in Q2 2014.
  • 875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.